Mendor, a Finish diabetes technologies and services company, raised $11.7 million in a Series B financing round, aiming for global expansion.
Funding was led by Finnish entrepreneur and investor Risto Siilasmaa, joined by Life Sciences Partners (LSP), Finnish Industry Investment Ltd., Finnish Mutual Pension Insurance Company Ilmarinen, private Finnish investment group Biothom and the Finnvera Venture Capital as a returning investor.
Neoprobe Corp. (NYSE Amex:NEOP) is getting a new chief executive and, perhaps, a new board member.
The Dublin, Ohio-based cancer diagnostics firm announced that CEO David Bupp will be replaced by chief development officer Mark Pykett on April 15.
RainDance Technologies Inc. hired Laura Deming to be the company’s senior vice president of product development and Joseph Malandrakis as senior product development counsel.
The Lexington, Mass.-based company, which makes microdroplet-based technologies for the life science and research markets, said Deming will oversee the long-range product planning and strategy.
MassDevice Network
@MassDevice
LinkedIn
YouTube